Navigation Links
Cardiogenesis Corporation to Report 2010 Third Quarter Results on November 3rd
Date:10/20/2010

IRVINE, Calif., Oct. 20 /PRNewswire-FirstCall/ -- Cardiogenesis Corporation (OTCQB: CGCP) announced that the company will release results for its third quarter ended September 30, 2010 on Wednesday, November 3, 2010.  The company added that Paul J. McCormick, its Executive Chairman, and William R. Abbott, its Senior Vice President and Chief Financial Officer, will host an investor conference call that day at 5:00 p.m. Eastern time (2:00 p.m. Pacific time) to review the company's financial results and business outlook.

The call is open to all interested investors through a live audio broadcast via the Internet at www.cardiogenesis.com.  The call also will be available to investors and analysts by dialing (866) 783-2145 within the U.S. and Canada and (857) 350-1604 from abroad.  The passcode is 25300206.

The webcast will be archived on the company's web site and will be available for playback for seven days beginning shortly after the live webcast.  A telephonic playback of the conference call will be available beginning at 8:00 p.m. Eastern time on Wednesday, November 3, 2010, and continue through 8:00 p.m. Eastern time on Wednesday, November 10, 2010.  The replay can be accessed by calling (888) 286-8010 within the U.S. and Canada and (617) 801-6888 from abroad.  The replay passcode is 55199188.

About Cardiogenesis Corporation

Cardiogenesis is a medical device company specializing in the treatment of cardiovascular disease and is a leader in devices that stimulate cardiac angiogenesis.  The company's market leading Holmium:YAG laser system and disposable fiber-optic accessories are used to perform a FDA-cleared surgical procedure known as Transmyocardial Revascularization (TMR) to treat patients suffering from angina.  Surgical products and accessories for the Cardiogenesis TMR procedure, which are marketed in the U.S. and around the world, have been shown to reduce angina and improve the quality of life in patients with coronary artery disease.

For more information on the company and its products, please visit the Cardiogenesis company website at www.cardiogenesis.com.


'/>"/>
SOURCE Cardiogenesis Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Cardiogenesis Announces Preliminary Clinical Results With the PHOENIX System Combining TMR + Stem Cells
2. Cardiogenesis Announces Presentation of its PHOENIX(R) Combination TMR Plus Stem Cell Delivery System at the International Society of Minimally Invasive Cardiothoracic Surgeons (ISMICS) Annual Meeting
3. Cardiogenesis Reports Third Quarter 2009 Results
4. Cardiogenesis Corporation to Present at Noble Financial - ONTRACK 2010
5. Cardiogenesis (CGCP) Listing Upgraded to New OTCQB(TM) Market for All U.S. Registered and Reporting OTC Securities
6. Cardiogenesis Corporation to Report 2010 Second Quarter Results on August 4th
7. Cardiogenesis Executive Chairman Paul J. McCormick Updates Commercial and Regulatory Progress in Interview With Wall Street Reporter, Available Online
8. Cardiogenesis Enrolls First Two Patients in Its Feasibility Study of the PHOENIX® Combination Delivery System
9. Genaera Corporation Presents Interim Phase 1 Data for Obesity Compound Trodusquemine (MSI-1436) at IBC Conference
10. CEL-SCI Corporation Releases Letter to Shareholders
11. Alfacell Corporation to Present at UBS Global Life Sciences Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/7/2017)... STOCKHOLM , Sept. 7, 2017 NuvoAir ... Air Smart Spirometer, announced today a partnership with Novartis Pharma ... partnership solidifies NuvoAir,s position as the leading mobile spirometry platform ... respiratory patients. ... spirometry test ...
(Date:9/6/2017)... 2017  Medical professionals are expected to ... treating their patients. Medical simulations offer clinicians ... patients. Simulation provides a safe method for ... procedures, refine techniques and build confidence, without ... technology, such as augmented reality, will now ...
(Date:9/5/2017)... , Sept. 5, 2017 Sapheneia and Scannerside ... solution. Scannerside DoseCheck is a third-party Vendor neutral CT ... scanners and allows compliance with current MITA standards. ... XR 29 DoseCheck solution is specifically designed to provide ... of potential radiation doses over a predefined threshold. Scannerside ...
Breaking Medicine Technology:
(Date:9/19/2017)... ... September 19, 2017 , ... ... a board-certified veterinary oncologist, has agreed to serve as strategic adviser to ... Dr. Tripp is founder of the Bridge Animal Referral Center (BARC) in ...
(Date:9/19/2017)... TX (PRWEB) , ... September 19, 2017 , ... ... the United States, named Dr. Howard Ng, as the new Medical Director of its ... be the new facility Medical Director of our Pflugerville- FM 685 location,” said Dr. ...
(Date:9/19/2017)... , ... September 19, 2017 , ... Ron Norman, CEO ... today the importance of making a distinct rather than generic impression in the job ... to look through a stack of resumes knows that the first impression they give ...
(Date:9/19/2017)... ... September 19, 2017 , ... When it comes to household safety, there are ... on how to keep babies and toddlers safe, and there's no better time for ... Great Time to Check Labels, Brands that sell all kinds of common consumer products ...
(Date:9/19/2017)... ... September 19, 2017 , ... ... app offering. The new app provides a modern design with a more streamlined ... experience. , The fred’s Pharmacy mobile app includes hundreds of digital coupons that ...
Breaking Medicine News(10 mins):